Keeps Biopharma Inc. (KOSDAQ:256940)

Keeps Biopharma Revenue

Keeps Biopharma had revenue of 59.44B KRW in the quarter ending March 31, 2026, with 46.23% growth. This brings the company's revenue in the last twelve months to 188.94B, up 38.39% year-over-year. In the year 2025, Keeps Biopharma had annual revenue of 170.15B with 33.36% growth.

• Revenue (ttm): 188.94B
• Revenue Growth: +38.39%
• P/S Ratio: 0.68
• Revenue / Employee: 1.73B
• Employees: 109
• Market Cap: 129.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	170.15B	42.56B	33.36%
Dec 31, 2024	127.58B	35.45B	38.48%
Dec 31, 2023	92.13B	77.52B	530.30%
Dec 31, 2022	14.62B	10.36B	243.08%
Dec 31, 2021	4.26B	-10.96B	-72.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error